FDA approves Envarsus XR to prevent organ rejection in de novo kidney transplant patients Dec. 20, 2018
FDA approves Lynparza for first-line maintenance therapy in BRCA-mutated advanced ovarian cancer Dec. 20, 2018
Keytruda gets FDA approval for recurrent locally advanced or metastatic Merkel cell carcinoma Dec. 20, 2018
G1's phase II study of trilaciclib with topotecan in second-/third-line SCLC meets primary endpoints Dec. 20, 2018
Gilead and Scholar Rock enter collaboration to develop novel therapies for fibrotic diseases Dec. 20, 2018
RSS